We just received data on a new analyst forecast for $RCT. Blair Abernethy from Rosenblatt set a price target of 5.0 for RCT.
To track analyst ratings and price targets for $RCT, check out Quiver Quantitative's $RCT forecast page.
Should you buy $RCT?
Some analysts are better than others. To view the past performance of Rosenblatt, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$RCT Price Targets
Multiple analysts have issued price targets for $RCT recently. We have seen 2 analysts offer price targets for $RCT in the last 6 months, with a median target of $4.75.
Here are some recent targets:
- Blair Abernethy from Rosenblatt set a target price of $5.0 on 01/15/2026
- Rohit Kulkarni from Roth Capital set a target price of $4.5 on 12/16/2025
$RCT Hedge Fund Activity
We have seen 6 institutional investors add shares of $RCT stock to their portfolio, and 1 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG added 315,016 shares (+2359.8%) to their portfolio in Q3 2025, for an estimated $570,178
- GLOBAL VALUE INVESTMENT CORP. added 46,855 shares (+4.5%) to their portfolio in Q3 2025, for an estimated $84,807
- GEODE CAPITAL MANAGEMENT, LLC added 20,569 shares (+inf%) to their portfolio in Q3 2025, for an estimated $37,229
- JANE STREET GROUP, LLC added 13,944 shares (+inf%) to their portfolio in Q3 2025, for an estimated $25,238
- 4WEALTH ADVISORS, INC. added 12,425 shares (+inf%) to their portfolio in Q3 2025, for an estimated $22,489
- CACHETECH INC. added 2,415 shares (+13.5%) to their portfolio in Q3 2025, for an estimated $4,371
- TOWER RESEARCH CAPITAL LLC (TRC) removed 835 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $1,511
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
